|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.39 USD | -7.49% |
|
-4.48% | +11.12% |
TriSalus Life Sciences, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 18.51 million compared to USD 12.4 million a year ago. Net loss was USD 59.04 million compared to USD 47.19 million a year ago.
Basic loss per share from continuing operations was USD 6.73 compared to USD 161.55 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +11.12% | 264M | |
| +9.42% | 115B | |
| +11.84% | 106B | |
| -2.65% | 21.96B | |
| -14.15% | 21.87B | |
| -5.29% | 19.21B | |
| -4.16% | 18.08B | |
| -38.29% | 17.71B | |
| +7.99% | 14.32B | |
| +36.24% | 12.42B |
TRISALUS LIFE SCIENCES, INC. 
